Skip to content
10-Q

Quarterly Report

ALLOS THERAPEUTICS INC

0001104659-12-053961

← back to feed
Filed
Aug 3, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 1, 2012 106.98M sh
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$10.16M
Cash And Equivalents Q2 2012 · Jun 30, 2012 $87.56M
Cash And Equivalents Q2 2012 · Dec 31, 2011 $87.37M
Stockholders Equity Q2 2012 · Jun 30, 2012 $65.34M
Stockholders Equity Q2 2012 · Dec 31, 2011 $79.3M
Current Liabilities Q2 2012 · Jun 30, 2012 $19.45M
Current Liabilities Q2 2012 · Dec 31, 2011 $20.96M
Current Assets Q2 2012 · Jun 30, 2012 $100.43M
Current Assets Q2 2012 · Dec 31, 2011 $115.83M
Total Assets Q2 2012 · Jun 30, 2012 $106.03M
Total Assets Q2 2012 · Dec 31, 2011 $122.08M
Sga Expense Q2 2012 · Jun 30, 2012 $14.58M
Sga Expense Q2 2012 · Jun 30, 2012 $30.02M
Net Income Q2 2012 · Jun 30, 2012 −$7.97M
Net Income Q2 2012 · Jun 30, 2012 −$19.29M
Operating Income Q2 2012 · Jun 30, 2012 −$7.99M
Operating Income Q2 2012 · Jun 30, 2012 −$19.31M
Revenue Q2 2012 · Jun 30, 2012 $13.47M
Revenue Q2 2012 · Jun 30, 2012 $24.81M